Liquidia Corporation Common Stock vs SailPoint Inc. Common Stock — how do they compare? Liquidia Corporation Common Stock trades at $33.46 (market cap $2.40B), while SailPoint Inc. Common Stock trades at $19.03 (market cap $11.06B). The key difference: SailPoint Inc. Common Stock is far larger — about 4.6× Liquidia Corporation Common Stock's market cap, and SailPoint Inc. Common Stock is trading nearer its 52-week high, Liquidia Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and SailPoint Inc. Common Stock for 0 Days on average.
| LQDA | SAIL | |
|---|---|---|
Market Cap | $2.40B | $11.06B |
Volume | 2,857,547 | 3,269,663 |
Sector | Health | Technology |
52-Week High | $91.03 | $22.85 |
52-Week Low | $22.02 | $10.49 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.30B | $10.76B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →SailPoint, Inc. develops identity security software that helps enterprises manage and govern access to applications and data across users, machines, and AI agents. Its unified identity security platform combines automation and intelligence to control identity-related risk at scale for large organizations.
Read more on SAIL →